八旬老人EVAR与保守管理结局的回顾性队列研究
该回顾性队列纳入2010至2024年Somerset与North Devon血管网络中因肾下腹主动脉瘤考虑EVAR的八旬老人393例,其中159例接受EVAR、190例不适合干预、44例自选保守管理。倾向评分匹配后EVAR组生存仅延长152天(P=.13),无统计学差异;AAA>6cm与更短生存相关。
要点
- 八旬老人自选保守管理的长期生存与择期EVAR无统计学显著差异。
- 腹主动脉瘤>6cm与更短生存相关,保守管理AAA<6cm者生存优于更大动脉瘤。
- EVAR围手术期死亡低,但非动脉瘤相关死亡可能削弱其长期获益。
核心结论
- 在八旬老人中,择期EVAR围手术期死亡率低,但与自选保守管理相比长期生存无统计学显著差异。
- 腹主动脉瘤>6cm与更短生存相关。
- 结果可辅助共享决策,并支持进一步研究八旬老人的治疗阈值。
研究设计与样本
- 回顾性队列研究,纳入2010年1月1日至2024年1月1日Somerset与North Devon血管网络中因肾下腹主动脉瘤考虑EVAR的八旬老人。
- 排除年龄<80岁、考虑开放修复及非择期手术者。
- 共识别393例八旬老人,采用倾向评分匹配比较择期EVAR与自选保守管理。
主要发现
- 393例中159例(40.3%)接受EVAR,190例(48.1%)不适合干预,44例(11.6%)被提供EVAR但自选保守管理。
- 自选保守管理者较EVAR者年龄更大(P<.001)、动脉瘤更小(P=.048),男性比例更低(P=.182)。
- 未调整分析中EVAR患者中位生存延长2.01年(P<.001);倾向评分匹配后EVAR组生存延长152天(P=.13)。
- AAA<6cm的保守管理生存长于更大动脉瘤(3.73 vs 2.26年,P=.003)。
- 自选保守管理患者死亡率低于已发表文献。
临床怎么用
- 对八旬老人腹主动脉瘤决策时应结合动脉瘤大小与预期寿命进行共享决策。
- AAA>6cm的八旬老人可能生存更短,需更谨慎评估干预获益。
- EVAR围手术期死亡低,但需关注非动脉瘤相关死亡对长期获益的影响。
局限性
- 为单网络回顾性队列研究,自选保守管理组样本量较小(44例)。
- 倾向评分匹配后生存差异未达统计学显著(P=.13),可能受样本量限制。
- 研究为探索性分析,结论需进一步研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Historically, conservative management of above-threshold abdominal aortic aneurysm (AAA) is associated with poor outcomes; however, there is limited contemporary data on risk of premature mortality in elderly patients either unfit for intervention or self-selecting conservative management. This exploratory study investigates whether amongst octogenarians deemed fit for endovascular aneurysm repair (EVAR), long-term survival differs for conservative management compared with elective EVAR. METHODS: The cohort comprised octogenarians with infrarenal AAA considered for EVAR in the Somerset and North Devon Vascular Network between 1 January 2010 to 1 January 2024. Exclusion criteria were age <80, consideration for open repair, and nonelective procedures. Propensity score matching was performed to compare patients undergoing elective EVAR and self-selecting conservative management. RESULTS: 393 octogenarians were identified. Of them, 159 (40.3%) underwent EVAR, 190 (48.1%) were unfit for intervention, and 44 (11.6%) were offered EVAR but self-selected conservative management. Patients self-selecting conservative management were older (P < .001), had smaller aneurysms (P = .048), and were less frequently male (P = .182) than those undergoing EVAR. On unadjusted analysis, median survival was 2.01 years longer for EVAR patients (P < .001). After propensity-score matching, survival was 152 days longer for the EVAR group (P = .13). Conservative management of AAA < 6cm was associated with longer survival than larger aneurysms (3.73 vs 2.26 years, P = .003). Patients self-selecting conservative management had lower mortality compared with the published literature. CONCLUSIONS: In our cohort, octogenarians undergoing EVAR experience low periprocedural mortality, but no statistically significant difference in long-term survival was observed over patients self-selecting conservative management. An abdominal aortic aneurysm > 6cm is associated with shorter survival. These results inform shared decision-making and support further investigation of treatment thresholds in octogenarians.Clinical ImpactAs the population ages an increasing number of octogenarians will be diagnosed with above-threshold AAA. Decision making for octogenarians with AAA is challenging, as procedure-related morbidity and mortality, aneurysm rupture risk, and life expectancy must be considered. This study investigates the outcomes of octogenarians that declined elective intervention for above-threshold AAA. This is the first study we are aware of investigating this patient group; historically, conservatively managed patients have been considered together. The results suggest that for octogenarians the benefit of elective EVAR is marginal, mostly due to high incidence of non-aneurysm-related mortality. This informs shared decision making for octogenarians.
引用
- Vaughan-Burleigh S, Mitchell A, Wijaya A, et al. Outcomes in Octogenarians Offered EVAR and Electing for Conservative Management: A Retrospective Cohort Study. J Endovasc Ther. 2026. PMID: 42528127. doi:10.1177/15266028261471727
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。